Condition: ST Segment Elevation Myocardial Infarction · Sponsor: Rigshospitalet, Denmark
In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI
This description comes directly from the study's public registry record.
Thomas Engstrøm, DMSci · +4535458444 · thomas.engstroem@regionh.dk
Jacob Lønborg, DMSci · +4535458176 · jacob.thomsen.loenborg01@regionh.dk
Always discuss trial participation with your own doctor first.
| The Heart Center, Rigshospitalet, University of Copenhagen | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03787745